GSK plc won U.S. FDA clearance for bepirovirsen under the brand name Hibsago, marking the first antisense oligonucleotide (ASO) for chronic hepatitis B.
Australia must make biotechnology a strategic national industry and build on its clinical trial strengths as political pressure on U.S. scientific institutions and China’s rise reshape global drug ...
Roche Holding AG turned once again to Jiangsu Hansoh Pharmaceutical Group Co. Ltd. to source novel antibody-drug conjugates ...
New blood-based biomarker tests that detect Alzheimer’s before symptoms appear are poised to transform the clinical landscape by catching the disease when controlling for risk factors is known to have ...
Visara Inc., a majority-owned ophthalmology subsidiary of Novabridge Biosciences Inc., has entered into an asset purchase option agreement with Yolo Immune Inc.
Hitting statistical significance and proof of concept in phase II for bipolar mania, Rapport Therapeutics Inc. is moving to ...
Although a mediated settlement is already on the table awaiting court approval, the U.S. Court of Appeals for the Fifth Circuit breathed new life into Cassava Sciences Inc.’s fight to stave off a ...
The Indian government issued a new drug pricing order that would impose a 30% cap on supply chain margins for 137 cancer ...
Beating other PD-1 therapies to the finish line, GSK plc’s Jemperli (dostarlimab) secured accelerated approval from the U.S.
Life sciences investors are raising billions of dollars in fresh capital, with a cluster of new funds and acquisition ...
Labcorp Holdings Inc. appears to be on an acquisition spree. It has agreed to buy the Prenatal Health testing business of ...
Abbott Laboratories received CE mark certification for the Cologuard Plus, a stool-based DNA test designed to detect both colorectal cancer and advanced precancerous lesions. The test was developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results